Related Experiment Videos
Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease
1Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4605, USA.
Seminars in Hematology
|October 29, 2003
Summary
Human genetic variation offers insights into complex diseases like leukemia and thrombosis. Understanding genetic variants, including single-nucleotide polymorphisms (SNPs), can personalize treatments and advance hematological disorder therapies.
Area of Science:
- Genomics
- Human Genetics
- Medical Genetics
Background:
- The human genome project revealed extensive genetic variation among individuals.
- Genetic variations play a role in susceptibility to complex diseases and interactions with environmental factors.
Purpose of the Study:
- To explore the application of human genetic variation in understanding complex diseases.
- To investigate the potential of genetic variants, such as SNPs, as disease modifiers.
- To highlight the role of genomics in advancing pharmacogenomics and targeted therapies for hematological disorders.
Main Methods:
- Analysis of human genome sequences to identify genetic variations.
- Correlating genetic variants with complex diseases like leukemia and thrombosis.
- Investigating the impact of genetic variants on disease susceptibility and progression.
Main Results:
- Recognition of the vast scope of human genetic variation.
- Evidence for new susceptibility genes and gene-environment interactions.
- Identification of genetic variants as potential disease modifiers.
Conclusions:
- Human genetic variation is a powerful tool for dissecting the genetics of complex diseases.
- Single-nucleotide polymorphisms (SNPs) can serve as crucial markers for disease investigation.
- Genomic insights are essential for developing targeted therapies for hematological disorders and advancing pharmacogenomics.